Enbrel

300,00 332,00 

Therapeutic TNF-α-inhibitor from the original Enbrel commercial drug targeting the TNF-α-antigen.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Certificate of Analysis (CoA)* Original therapeutic expiry date PriceQuantityTotal
aliquot 25802S67398no02/2019 332,00 
-
+
332,00 
spinner
aliquot 50402T21782no04/2019 332,00 
-
+
332,00 
spinner
aliquot 50402T64915no06/2019 332,00 
-
+
332,00 
spinner
aliquot 50402W02981no08/2019 332,00 
-
+
332,00 
spinner
aliquot 50402W42283no10/2019 332,00 
-
+
332,00 
spinner
aliquot 25802W32559no12/2019 332,00 
-
+
332,00 
spinner
aliquot 50402X44248no04/2020 332,00 
-
+
332,00 
spinner
dilution11000,1NOT APPLICABLEnoNOT APPLICABLE 300,00 
-
+
300,00 
spinner

Category: SKU: Enbrel

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Etanercept

Antigen

TNF-α

Product Concentration [mg/mL]

1, 25, 50

Volume per Vial [µL]

40, 80, 100

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, S67398, W32559, T64915, W02981, X44248, -, T21782, W42283

Certificate of Analysis (CoA)*

no

Original therapeutic expiry date

-, 02/2019, 02/2020, 04/2019, 04/2020, 06/2019, 08/2019, 10/2019, 12/2019, NOT APPLICABLE